Tonix Pharmaceuticals Holding Corp. — Form D/A

Tonix Pharmaceuticals Holding Corp. of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2012-12-26. The offering totals $4.0M, of which $3.3M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Stuart DavidsonDirectorSan Francisco, CA
Patrick GraceDirectorNEW YORK, NY
Donald LandryDirectorNEW YORK, NY
Ernest MarioDirectorPalo Alto, CA
Charles MatherDirectorNEW YORK, NY
John RhodesDirectorPhoenix, AZ
Samuel SaksDirectorSan Francisco, CA
Bruce DaughertyExecutive OfficerNEW YORK, NY
Leland GershellExecutive OfficerBEVERLY HILLS, CA
Gregory SullivanExecutive OfficerWilmington, MA
DAVID MOSSDirectorFORT LAUDERDALE, FL
Benjamin SelzerExecutive OfficerLong Island City, NY
Ernest W MarioDirectorNew York, NY
Bradley SaengerExecutive OfficerNew York, NY
Stuart Smith DavidsonDirectorNew York, NY
Donald W LandryDirectorNew York, NY
Seth LedermanDirectorNew York, NY
Seth LedermanExecutive OfficerNew York, NY
John E RhodesDirectorNew York, NY
Charles E Mather IVDirectorNew York, NY
Samuel E SaksDirectorNew York, NY
Margaret Smith BellDirectorNew York, NY
Patrick Smith GraceDirectorNew York, NY
Rhonda RosenExecutive OfficerHOUSTON, TX
Susan KerridgeExecutive OfficerNEW YORK, NY

Other filings by this issuer (5)

FiledFormOfferingSold
2017-10-10D$15.3M$315K
2012-12-12D$3.0M$2.3M
2012-11-20D$3.0M$710K
2012-01-31D$10.0M$4.3M
2011-10-20D$3.0M$1.6M

More